Pharma's Almanac TV
PA TV
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
MilliporeSigma
12 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Capacity Expansion
MilliporeSigma Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity with $110 Million Facility
PR-M04-20-NI-032
Purification
High-Productivity Membrane Chromatography to Enable Next-Generation Purification of Monoclonal Antibodies
PAP-Q4-19-CL-023
Biopharma
Bioprocess of the Future: What’s In it for Biomanufacturers?
PAP-Q2-2019-CL-026
M Lab
MilliporeSigma Opens First M Lab™ Collaboration Center in Europe
PR-M03-19-NI-060
CRISPR
MilliporeSigma Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M03-19-NI-009
Awards
MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018
PR-M11-18-NI-101
CRISPR
MilliporeSigma Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology
PR-M09-18-NI-046
CRISPR
MilliporeSigma Receives Two More Patents for CRISPR Technology
PR-M02-18-NI-86
BioLife Solutions Executes OEM Agreement with MilliporeSigma
PR-M02-18-NI-57
Innovation
MilliporeSigma Expands Celonic's Upstream Capabilities with Mobius® Single-use Bioreactors
PR-M09-17-NI-004
CRISPR
MilliporeSigma Increases the Efficiency of Gene Editing
PAO-M05-17-NI-030
Innovation
Millipore Sigma Sponsoring LabCentral
PAO-M05-17-NI-002
